Posted by Michael Wonder on 18 Nov 2015
Amgen's cholesterol-buster Repatha turned down for NHS use
18 November 2015 - NICE has turned down Amgen’s Repatha - the world’s first approved PCSK9 inhibitor - as an option for people with high cholesterol and mixed dyslipidaemia.
For more details, go to: http://www.pharmatimes.com/Article/15-11-18/Amgen_s_cholesterol-buster_Repatha_turned_down_for_NHS_use.aspx
